Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.385 EUR | -0.83% | +0.85% | -13.71% |
Business Summary
Number of employees: 234
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Therapeutics
100.0
%
| 26 | 53.0 % | 18 | 100.0 % | -28.95% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 26 | 53.0 % | 18 | 100.0 % | -28.95% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Sourdive
FOU | Founder | 57 | 99-12-19 |
André Choulika
FOU | Founder | 59 | 99-12-19 |
Bing C. Wang
DFI | Director of Finance/CFO | 47 | 22-02-09 |
Mark Frattini
CTO | Chief Tech/Sci/R&D Officer | 58 | 20-07-31 |
Stephan Reynier
CMP | Compliance Officer | 55 | 11-03-31 |
Chief Tech/Sci/R&D Officer | 61 | 00-12-31 | |
Arthur Stril
IRC | Investor Relations Contact | 35 | 18-06-30 |
Human Resources Officer | 54 | 20-11-15 | |
Steve Doares
PRN | Corporate Officer/Principal | - | 20-07-20 |
General Counsel | 42 | 07-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 75 | 20-11-04 | |
André Choulika
FOU | Founder | 59 | 99-12-19 |
David Sourdive
FOU | Founder | 57 | 99-12-19 |
Laurent Arthaud
BRD | Director/Board Member | 61 | 11-10-27 |
Pierre Bastid
BRD | Director/Board Member | 69 | 11-10-27 |
Director/Board Member | 57 | 22-06-27 | |
Donald Bergstrom
BRD | Director/Board Member | 52 | 22-06-27 |
Rainer Boehm
BRD | Director/Board Member | 63 | 17-06-28 |
Cécile Chartier
BRD | Director/Board Member | - | 23-06-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 55,583,768 | 55,583,768 ( 100.00 %) | 0 | 100.00 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
CALYXTPAR 2.28% | 479,264 | 2.28% | 10,764,269 $ |
Company contact information
Sector
Sales per Business
Sales per region
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.99% | 184M | |
+4.09% | 43.84B | |
+47.81% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- ALCLS Stock
- Company Cellectis S.A.